Species and genus level resolution analysis of gut microbiota in Clostridium difficile patients following fecal microbiota transplantation

Microbiome

Volumn 2, Issue 1, 2014, Pages

  Shankar, Vijay ^a   Hamilton, Matthew J ^b   Khoruts, Alexander ^c   Kilburn, Amanda ^a   Unno, Tatsuya ^b   Paliy, Oleg ^a   Sadowsky, Michael J ^b  

^a WRIGHT STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Clostridium difficile; Fecal microbiota transplantation; Microbiota; Microbiota Array; Microflora

Indexed keywords

GENOMIC DNA;

ARTICLE; BACILLI; CLOSTRIDIA; CLOSTRIDIUM DIFFICILE INFECTION; DNA MICROARRAY; ENTEROBACTER; FECAL MICROBIOTA TRANSPLANTATION; FECES MICROFLORA; FLUORESCENCE IN SITU HYBRIDIZATION; GAMMAPROTEOBACTERIA; GENE DOSAGE; HIGH THROUGHPUT SEQUENCING; HUMAN; INTESTINE FLORA; LACTOBACILLUS; MICROARRAY ANALYSIS; MICROBIAL COMMUNITY; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STREPTOCOCCUS; TRANSPLANTATION;

BACILLI (CLASS); CLOSTRIDIA; CLOSTRIDIUM DIFFICILE; COPROCOCCUS; ENTEROBACTER; FAECALIBACTERIUM; GAMMAPROTEOBACTERIA; LACTOBACILLUS; STREPTOCOCCUS;

EID: 84924533173     PISSN: None     EISSN: 20492618     Source Type: Journal    
DOI: 10.1186/2049-2618-2-13     Document Type: Article

References (48)

1. Khardori N. Antibiotics-past, present, and future. Med Clin North Am 2006, 90:1049-1076. 10.1016/j.mcna.2006.06.007, 17116436.
2. Kelly CP, LaMont JT. Clostridium difficile infection. Annu Rev Med 1998, 49:375-390. 10.1146/annurev.med.49.1.375, 9509270.
3. Arvand M, Moser V, Schwehn C, Bettge-Weller G, Hensgens MP, Kuijper EJ. High prevalence of Clostridium difficile colonization among nursing home residents in Hesse, Germany. PLoS ONE 2012, 7:e30183. 10.1371/journal.pone.0030183, 3256225, 22253917.
4. Curry SR, Muto CA, Schlackman JL, Pasculle AW, Shutt KA, Marsh JW, Harrison LH. Use of multilocus variable number of tandem repeats analysis genotyping to determine the role of asymptomatic carriers in Clostridium difficile transmission. Clin Infect Dis 2013, 57:1094-1102. 10.1093/cid/cit475, 23881150.
5. Eyre DW, Cule ML, Wilson DJ, Griffiths D, Vaughan A, O'Connor L, Ip CL, Golubchik T, Batty EM, Finney JM, Wyllie DH, Didelot X, Piazza P, Bowden R, Dingle KE, Harding RM, Crook DW, Wilcox MH, Peto TEA, Walker AS. Diverse sources of C. difficile infection identified on whole-genome sequencing. N Engl J Med 2013, 369:1195-1205. 10.1056/NEJMoa1216064, 3868928, 24066741.
6. Bakken JS, Borody T, Brandt LJ, Brill JV, Demarco DC, Franzos MA, Kelly C, Khoruts A, Louie T, Martinelli LP, Moore TA, Russell G, Surawicz C, . Fecal Microbiota Transplantation Group Treating Clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol 2011, 9:1044-1049. 10.1016/j.cgh.2011.08.014, 3223289, 21871249, Fecal Microbiota Transplantation Group.
7. van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal EG, de Vos WM, Visser CE, Kuijper EJ, Bartelsman JF, Tijssen JG, Speelman P, Dijkgraaf MG, Keller JJ. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 2013, 368:407-415. 10.1056/NEJMoa1205037, 23323867.
8. Khoruts A, Dicksved J, Jansson JK, Sadowsky MJ. Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea. J Clin Gastroenterol 2010, 44:354-360.
9. Hamilton MJ, Weingarden AR, Unno T, Khoruts A, Sadowsky MJ. High-throughput DNA sequence analysis reveals stable engraftment of gut microbiota following transplantation of previously frozen fecal bacteria. Gut Microbes 2013, 4:125-135. 10.4161/gmic.23571, 3595072, 23333862.
10. Paliy O, Kenche H, Abernathy F, Michail S. High-throughput quantitative analysis of the human intestinal microbiota with a phylogenetic microarray. Appl Environ Microbiol 2009, 75:3572-3579. 10.1128/AEM.02764-08, 2687317, 19363078.
11. Rigsbee L, Agans R, Shankar V, Kenche H, Khamis HJ, Michail S, Paliy O. Quantitative profiling of gut microbiota of children with diarrhea-predominant Irritable Bowel Syndrome. Am J Gastroenterol 2012, 107:1740-1751. 10.1038/ajg.2012.287, 22986438.
12. Rigsbee L, Agans R, Foy BD, Paliy O. Optimizing the analysis of human intestinal microbiota with phylogenetic microarray. FEMS Microbiol Ecol 2011, 75:332-342. 10.1111/j.1574-6941.2010.01009.x, 3077101, 21155851.
13. Shankar V, Agans R, Holmes B, Raymer M, Paliy O. Do gut microbial communities differ in pediatric IBS and health?. Gut Microbes 2013, 4:347-352. 10.4161/gmic.24827, 23674073.
14. Hamilton MJ, Weingarden AR, Sadowsky MJ, Khoruts A. Standardized frozen preparation for transplantation of fecal microbiota for recurrent clostridium difficile infection. Am J Gastroenterol 2012, 107:761-767. 10.1038/ajg.2011.482, 22290405.
15. Paliy O, Foy B. Mathematical modeling of 16S ribosomal DNA amplification reveals optimal conditions for the interrogation of complex microbial communities with phylogenetic microarrays. Bioinformatics 2011, 27:2134-2140. 10.1093/bioinformatics/btr326, 3137216, 21653518.
16. Agans R, Rigsbee L, Kenche H, Michail S, Khamis HJ, Paliy O. Distal gut microbiota of adolescent children is different from that of adults. FEMS Microbiol Ecol 2011, 77:404-412. 10.1111/j.1574-6941.2011.01120.x, 21539582.
17. Hamady M, Lozupone C, Knight R. Fast UniFrac: facilitating high-throughput phylogenetic analyses of microbial communities including analysis of pyrosequencing and PhyloChip data. ISME J 2010, 4:17-27. 10.1038/ismej.2009.97, 2797552, 19710709.
18. Schloss PD, Westcott SL, Ryabin T, Hall JR, Hartmann M, Hollister EB, Lesniewski RA, Oakley BB, Parks DH, Robinson CJ, Sahl JW, Stres B, Thallinger GG, Van Horn DJ, Weber CF. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol 2009, 75:7537-7541. 10.1128/AEM.01541-09, 2786419, 19801464.
19. Cole JR, Wang Q, Cardenas E, Fish J, Chai B, Farris RJ, Kulam-Syed-Mohideen AS, McGarrell DM, Marsh T, Garrity GM, Tiedje JM. The ribosomal database project: improved alignments and new tools for rRNA analysis. Nucleic Acids Res 2009, 37:D141-145. 10.1093/nar/gkn879, 2686447, 19004872.
20. Ramette A. Multivariate analyses in microbial ecology. FEMS Microbiol Ecol 2007, 62:142-160. 10.1111/j.1574-6941.2007.00375.x, 2121141, 17892477.
21. Sekirov I, Russell SL, Antunes LC, Finlay BB. Gut microbiota in health and disease. Physiol Rev 2010, 90:859-904. 10.1152/physrev.00045.2009, 20664075.
22. Griffiths D, Fawley W, Kachrimanidou M, Bowden R, Crook DW, Fung R, Golubchik T, Harding RM, Jeffery KJ, Jolley KA, Kirton R, Peto TE, Rees G, Stoesser N, Vaughan A, Walker AS, Young BC, Wilcox M, Dingle KE. Multilocus sequence typing of Clostridium difficile. J Clin Microbiol 2010, 48:770-778. 10.1128/JCM.01796-09, 2832416, 20042623.
23. Manges AR, Labbe A, Loo VG, Atherton JK, Behr MA, Masson L, Tellis PA, Brousseau R. Comparative metagenomic study of alterations to the intestinal microbiota and risk of nosocomial Clostridum difficile-associated disease. J Infect Dis 2010, 202:1877-1884. 10.1086/657319, 21050115.
24. Petrof EO, Gloor GB, Vanner SJ, Weese SJ, Carter D, Daigneault MC, Brown EM, Schroeter K, Allen-Vercoe E. Stool substitute transplant therapy for the eradication of Clostridium difficile infection: 'RePOOPulating' the gut. Microbiome 2013, 1:3. 10.1186/2049-2618-1-3, 3869191, 24467987.
25. Shahinas D, Silverman M, Sittler T, Chiu C, Kim P, Allen-Vercoe E, Weese S, Wong A, Low DE, Pillai DR. Toward an understanding of changes in diversity associated with fecal microbiome transplantation based on 16S rRNA gene deep sequencing. mBio 2012, doi:10.1128/mBio.00338-12.
26. Ananthakrishnan AN. Clostridium difficile infection: epidemiology, risk factors and management. Nat Rev Gastroenterol Hepatol 2011, 8:17-26. 10.1038/nrgastro.2010.190, 21119612.
27. Willing BP, Dicksved J, Halfvarson J, Andersson AF, Lucio M, Zheng Z, Jarnerot G, Tysk C, Jansson JK, Engstrand L. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology 2010, 139:1844-1854. e1841, 10.1053/j.gastro.2010.08.049, 20816835.
28. Booijink CC, El-Aidy S, Rajilic-Stojanovic M, Heilig HG, Troost FJ, Smidt H, Kleerebezem M, De Vos WM, Zoetendal EG. High temporal and inter-individual variation detected in the human ileal microbiota. Environ Microbiol 2010, 12:3213-3227. 10.1111/j.1462-2920.2010.02294.x, 20626454.
29. van den Bogert B, de Vos WM, Zoetendal EG, Kleerebezem M. Microarray analysis and barcoded pyrosequencing provide consistent microbial profiles depending on the source of human intestinal samples. Appl Environ Microbiol 2011, 77:2071-2080. 10.1128/AEM.02477-10, 3067328, 21257804.
30. Zoetendal EG, Raes J, van den Bogert B, Arumugam M, Booijink CC, Troost FJ, Bork P, Wels M, de Vos WM, Kleerebezem M. The human small intestinal microbiota is driven by rapid uptake and conversion of simple carbohydrates. ISME J 2012, 6:1415-1426. 10.1038/ismej.2011.212, 3379644, 22258098.
31. Anderson CM, Langford RF. Bacterial content of small intestine of children in health, in coeliac disease, and in fibrocystic disease of pancreas. Br Med J 1958, 1:803-806. 10.1136/bmj.1.5074.803, 2027979, 13510808.
32. Reuter G. The Lactobacillus and Bifidobacterium microflora of the human intestine: composition and succession. Curr Issues Intest Microbiol 2001, 2:43-53.
33. Sullivan A, Tornblom H, Lindberg G, Hammarlund B, Palmgren AC, Einarsson C, Nord CE. The micro-flora of the small bowel in health and disease. Anaerobe 2003, 9:11-14. 10.1016/S1075-9964(03)00060-X, 16887682.
34. Morgan XC, Tickle TL, Sokol H, Gevers D, Devaney KL, Ward DV, Reyes JA, Shah SA, LeLeiko N, Snapper SB, Bousvaros A, Korzenik J, Sands BE, Xavier RJ, Huttenhower C. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol 2012, 13:R79. 10.1186/gb-2012-13-9-r79, 3506950, 23013615.
35. Antharam VC, Li EC, Ishmael A, Sharma A, Mai V, Rand KH, Wang GP. Intestinal dysbiosis and depletion of butyrogenic bacteria in Clostridium difficile infection and nosocomial diarrhea. J Clin Microbiol 2013, 51:2884-2892. 10.1128/JCM.00845-13, 3754663, 23804381.
36. Meihoff WE, Kern F. Bile salt malabsorption in regional ileitis, ileal resection and mannitol-induced diarrhea. J Clin Invest 1968, 47:261-267. 10.1172/JCI105722, 297168, 12066774.
37. Swidsinski A, Loening-Baucke V, Vaneechoutte M, Doerffel Y. Active Crohn's disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora. Inflamm Bowel Dis 2008, 14:147-161. 10.1002/ibd.20330, 18050295.
38. Manichanh C, Reeder J, Gibert P, Varela E, Llopis M, Antolin M, Guigo R, Knight R, Guarner F. Reshaping the gut microbiome with bacterial transplantation and antibiotic intake. Genome Res 2010, 20:1411-1419. 10.1101/gr.107987.110, 2945190, 20736229.
39. Espey MG. Role of oxygen gradients in shaping redox relationships between the human intestine and its microbiota. Free Radic Biol Med 2013, 55:130-140.
40. Jarchum I, Liu M, Shi C, Equinda M, Pamer EG. Critical role for MyD88-mediated neutrophil recruitment during Clostridium difficile colitis. Infect Immun 2012, 80:2989-2996. 10.1128/IAI.00448-12, 3418725, 22689818.
41. Samuelson J. Why metronidazole is active against both bacteria and parasites. Antimicrob Agents Chemother 1999, 43:1533-1541. 89320, 10390199.
42. Watanakunakorn C. Mode of action and in-vitro activity of vancomycin. J Antimicrob Chemother 1984, (Suppl D):7-18.
43. Caporaso JG, Lauber CL, Costello EK, Berg-Lyons D, Gonzalez A, Stombaugh J, Knights D, Gajer P, Ravel J, Fierer N, Gordon JI, Knight R. Moving pictures of the human microbiome. Genome Biol 2011, 12:R50. 10.1186/gb-2011-12-5-r50, 3271711, 21624126.
44. Song Y, Garg S, Girotra M, Maddox C, von Rosenvinge EC, Dutta A, Dutta S, Fricke WF. Microbiota dynamics in patients treated with fecal microbiota transplantation for recurrent Clostridium difficile infection. PLoS ONE 2013, 8:e81330. 10.1371/journal.pone.0081330, 3841263, 24303043.
45. Landy J, Al-Hassi HO, McLaughlin SD, Walker AW, Ciclitira PJ, Nicholls RJ, Clark SK, Hart AL. Review article: faecal transplantation therapy for gastrointestinal disease. Aliment Pharmacol Ther 2011, 34:409-415. 10.1111/j.1365-2036.2011.04737.x, 21682755.
46. Guo B, Harstall C, Louie T, Veldhuyzen Van Zanten S, Dieleman LA. Systematic review: faecal transplantation for the treatment of Clostridium difficile-associated disease. Aliment Pharmacol Ther 2012, 35:865-875. 10.1111/j.1365-2036.2012.05033.x, 22360412.
47. Borody TJ, Khoruts A. Fecal microbiota transplantation and emerging applications. Nat Rev Gastroenterol Hepatol 2011, 9:88-96. 10.1038/nrgastro.2011.244, 22183182.
48. Aroniadis OC, Brandt LJ. Fecal microbiota transplantation: past, present and future. Curr Opin Gastroenterol 2012, 29:79-84.